These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16198665)

  • 1. The CYP2C9 genotype does not influence sildenafil pharmacokinetics in healthy volunteers.
    Jetter A; Lazar A; Schömig E; Fuhr U; Kinzig-Schippers M; Sörgel F
    Clin Pharmacol Ther; 2005 Oct; 78(4):441-3. PubMed ID: 16198665
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.
    Gupta M; Kovar A; Meibohm B
    J Clin Pharmacol; 2005 Sep; 45(9):987-1003. PubMed ID: 16100293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 5 phosphodiesterase inhibition: the focus shifts to the heart.
    Semigran MJ
    Circulation; 2005 Oct; 112(17):2589-91. PubMed ID: 16246958
    [No Abstract]   [Full Text] [Related]  

  • 5. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness duration determines selection].
    MMW Fortschr Med; 2006 Jul; 148(29-30):54-5. PubMed ID: 16910411
    [No Abstract]   [Full Text] [Related]  

  • 7. Sildenafil increases cerebrovascular reactivity: a transcranial Doppler study.
    Brenner S
    Neurology; 2006 May; 66(9):1455-6; author reply 1455-6. PubMed ID: 16682690
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potential of phosphodiesterase 5 inhibition for cardiovascular disease.
    Reffelmann T; Kloner RA
    Circulation; 2003 Jul; 108(2):239-44. PubMed ID: 12860892
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of type-5 phosphodiesterase: promising therapy for pulmonary hypertension.
    Watanabe H
    Intern Med; 2004 Oct; 43(10):891-3. PubMed ID: 15575233
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
    Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
    Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In sex dysfunctions--not just a "male issue". Don't forget women].
    MMW Fortschr Med; 2003 Sep; 145(35-36):51. PubMed ID: 14584212
    [No Abstract]   [Full Text] [Related]  

  • 12. Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.
    Bunnage ME; Mathias JP; Wood A; Miller D; Street SD
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6033-6. PubMed ID: 18951784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New potency pill. Treating (vascular) bed failure].
    MMW Fortschr Med; 2003 Jan; 145(5):51. PubMed ID: 12619215
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and phosphodiesterase 5 inhibitory activity of new sildenafil analogues containing a phosphonate group in the 5(')-sulfonamide moiety of phenyl ring.
    Kim DK; Young Lee J; Park HJ; Minh Thai K
    Bioorg Med Chem Lett; 2004 May; 14(9):2099-103. PubMed ID: 15080987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of peripheral and spinal phosphodiesterases 4 and 5 in inflammatory pain.
    Torres-López JE; Argüelles CF; Granados-Soto V
    Proc West Pharmacol Soc; 2002; 45():141-3. PubMed ID: 12434560
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers.
    Al-Ghazawi MA; Tutunji MS; AbuRuz SM
    Eur J Clin Pharmacol; 2010 Feb; 66(2):159-63. PubMed ID: 19830413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil can increase the response to inhaled nitric oxide.
    Bigatello LM; Hess D; Dennehy KC; Medoff BD; Hurford WE
    Anesthesiology; 2000 Jun; 92(6):1827-9. PubMed ID: 10839936
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in sperm motility after acute oral administration of sildenafil or tadalafil in young, infertile men.
    Pomara G; Morelli G; Canale D; Turchi P; Caglieresi C; Moschini C; Liguori G; Selli C; Macchia E; Martino E; Francesca F
    Fertil Steril; 2007 Oct; 88(4):860-5. PubMed ID: 17544419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR of tetracyclic pyrroloquinolones as phosphodiesterase 5 inhibitors.
    Jiang W; Alford VC; Qiu Y; Bhattacharjee S; John TM; Haynes-Johnson D; Kraft PJ; Lundeen SG; Sui Z
    Bioorg Med Chem; 2004 Mar; 12(6):1505-15. PubMed ID: 15018924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistaxis after sildenafil.
    Bott SR; Shergill I; Arya M
    J R Soc Med; 2002 Oct; 95(10):528. PubMed ID: 12356992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.